Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI?

Journal: Archives of Hematology Case Reports and Reviews (Vol.1, No. 1)

Publication Date: 2016-12-30

Authors : Maamar Kara Omar Aitmokhtar Adel Azaza Saber Seddiki Faiza Harbi Arezki Sik Kheireddine Merad; Salim Benkhedda;

Page : 005-006

Keywords : ;

Source : Download Find it from : Google Scholar

Abstract

ACS: Acute Coronary Syndrome; AF: Atrial Fibrillation; DAPT: Dual Antiplatelet Therapy; INR: InternationalNormalized Ratio; MI: Myocardial Infarction; PCI: Percutaneous Coronary Intervention; PIONEER AF-PCI: Open-Label, Randomized, Controlled, Multicenterstudy Exploring two Treatment Strategiesof Rivaroxaban and a Dose-Adjusted Oral Vitamink Antagonist Treatment Strategy in Subjectswith Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention; TIMI: Thrombolysis In Myocardial Infarction; VKA: Vitamin K Antagonist

Main Menu

Searching By

PARTNERS

Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI?

Abstract

Advertisement